Clinical Trials Sponsored by ProQR Therapeutics
Total 6261 results
-
Ascenta TherapeuticsCompletedSmall Cell Lung CancerUnited States, Russian Federation, Ukraine
-
Capstone TherapeuticsTerminatedRadius FractureUnited States
-
Amicus TherapeuticsCompleted
-
Allergy TherapeuticsCompletedType I HypersensitivityUnited States
-
Harbor TherapeuticsCompletedInsulin ResistanceUnited States
-
United TherapeuticsCompletedPulmonary Arterial Hypertension | Hypertension, PulmonaryUnited States
-
Halozyme TherapeuticsCompletedSuperficial Bladder CancerUnited States
-
ARYx TherapeuticsUnknownMyocardial Infarction | Atrial Fibrillation | Atrial Flutter | Cardiomyopathy | Venous Thromboembolic DiseaseUnited States
-
Aeris TherapeuticsTerminatedPulmonary EmphysemaNetherlands
-
Aegera TherapeuticsTerminatedHuman Mammary CarcinomaUnited States
-
Alaunos TherapeuticsCompletedAdvanced CancerUnited States
-
vTv TherapeuticsCompletedEmbolism and Thrombosis | Hip Fractures | Venous ThromboembolismDenmark, Czech Republic, Norway, Sweden
-
MediQuest TherapeuticsUnknownFingernail PsoriasisUnited Kingdom
-
TorreyPines TherapeuticsCompletedSjogren's Syndrome | XerostomiaUnited States
-
Aegera TherapeuticsTerminated
-
Amicus TherapeuticsCompletedGlycogen Storage Disease Type II | Pompe DiseaseUnited States
-
ImaRx TherapeuticsTerminatedAcute Ischemic StrokeUnited States, France
-
Bayhill TherapeuticsCompletedMultiple SclerosisUnited States, Canada
-
Introgen TherapeuticsUnknownCarcinoma, Squamous CellUnited States
-
Critical TherapeuticsCompleted
-
Aeris TherapeuticsTerminatedPulmonary EmphysemaIsrael
-
Aeris TherapeuticsCompletedPulmonary EmphysemaUnited States
-
Halozyme TherapeuticsCompleted
-
Wellstat TherapeuticsCompletedType 2 Diabetes MellitusUnited States
-
Wellstat TherapeuticsCompletedType 2 Diabetes MellitusUnited States
-
Intarcia TherapeuticsCompletedHepatitis CRussian Federation
-
Point TherapeuticsCompleted
-
Point TherapeuticsCompleted
-
MediQuest TherapeuticsCompletedRaynaud's Disease | Raynaud's Disease Secondary to Scleroderma | Raynaud's Disease Secondary to Autoimmune DiseaseUnited States
-
Cure TherapeuticsUnknown
-
Critical TherapeuticsTerminatedCoronary Disease | Heart Valve DiseasesUnited States
-
Wellstat TherapeuticsTerminatedSolid TumorsUnited States
-
Verismo TherapeuticsRecruiting
-
Ractigen Therapeutics.RecruitingNon-Muscle-Invasive Bladder Cancer (NMIBC)Australia
-
NeuShen TherapeuticsRecruiting
-
Monopar TherapeuticsRecruitingGastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Lung Cancer | Bladder Cancer | Urothelial Carcinoma | Triple-negative Breast Cancer | Solid Tumor, AdultAustralia
-
vTv TherapeuticsNot yet recruitingDiabetes Mellitus, Type 1
-
Enliven TherapeuticsRecruitingColorectal Cancer | HER2-positive Breast Cancer | HER2-positive Gastric Cancer | HER2 Amplification | HER2 Positive Solid TumorsUnited States
-
OX2 TherapeuticsRecruitingDiffuse Midline Glioma, H3 K27M-Mutant | Recurrent High Grade GliomaUnited States
-
Transcend TherapeuticsRecruitingA Single, Ascending Dose Evaluation of the Safety, Pharmacokinetics of Methylone in Healthy SubjectsPost Traumatic Stress DisorderAustralia
-
Remix TherapeuticsRecruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Acute Myeloid Leukemia Refractory | Higher Risk Myelodysplastic SyndromesUnited States
-
Encoded TherapeuticsRecruiting
-
Dianthus TherapeuticsRecruitingMyasthenia Gravis, GeneralizedUnited States
-
Intellia TherapeuticsNot yet recruitingHereditary AngioedemaFrance, New Zealand, United Kingdom
-
Aprea TherapeuticsNot yet recruitingAdvanced Solid Tumor
-
ReCode TherapeuticsRecruitingCystic FibrosisNew Zealand
-
Repare TherapeuticsRecruiting
-
NovelMed TherapeuticsNot yet recruitingAnti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
-
Quanta TherapeuticsRecruiting